Covered recipient · General Payments record
AOBO DU
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2019–2024
$8,933.63
- Reported across 245 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $753.43 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $295.14 | 5 |
| Janssen Pharmaceuticals, Inc | $210.26 | 3 |
| Acerta Pharma LLC | $141.97 | 2 |
| Novo Nordisk AS | $37.22 | 2 |
| Lilly USA, LLC | $35.47 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.31 | 1 |
| PFIZER INC. | $15.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.19 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103661630 | CMS |
| ABBVIE INC. | $22.37 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103661632 | CMS |
| ABBVIE INC. | $33.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103661634 | CMS |
| ABBVIE INC. | $101.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103661636 | CMS |
| ABBVIE INC. | $124.83 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103661638 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.01 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104643267 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.96 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104643093 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.31 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109936 | CMS |
| Janssen Pharmaceuticals, Inc | $82.48 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078003806 | CMS |
| Janssen Pharmaceuticals, Inc | $14.31 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078005206 | CMS |
| Janssen Pharmaceuticals, Inc | $113.47 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078004910 | CMS |
| Lilly USA, LLC | $15.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136061378 | CMS |
| Lilly USA, LLC | $19.56 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051161 | CMS |
| Novo Nordisk Inc | $15.80 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610330 | CMS |
| Novo Nordisk Inc | $21.42 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096664802 | CMS |
| PFIZER INC. | $15.06 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131150644 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.